Skip to main navigation Skip to search Skip to main content

MET42 - Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine when Administered Concomitantly with Routine Pediatric Vaccines in Healthy Infants and Toddlers

University at Buffalo

Project: Research

Project Details

StatusFinished
Effective start/end date06/12/19 → 12/31/22

Funding

  • DrugDev: $12,620.00